Private investor clients of Connection Capital, the specialist private client investment business, have invested £6.7 million (~USD $9.4 million) in MatOrtho, to support its international growth and product development.
Founded in 2010, MatOrtho designs, manufactures and commercializes orthopaedic implant devices. The company has achieved strong growth and has built a truly global presence, supplying implant devices into many of the world’s orthopaedic markets.
The MatOrtho range of advanced knee, hip, and finger replacement procedures consistently deliver clinically proven, best-in-class patient outcomes for implant performance and sustained use with better patient satisfaction.
The investment will enable MatOrtho to accelerate international expansion into new and existing markets and will support research and development as the company continues to develop the next generation of implant technology. The management team will be supported by experienced industry figure, Simon Cartmell, previously CEO of ApaTech, who has joined the board as a Non-Executive.
Mike Tuke, Chairman of MatOrtho says, “MatOrtho and Finsbury before that has always led with game changing implants which have established a leading-edge position in the orthopaedic implants sector, and there is still so much potential to develop innovative new products and increase our market penetration. Having the backing of Connection Capital will be invaluable as we look to accelerate the scaling-up of our business.”
Private investor clients of Connection Capital, the specialist private client investment business, have invested £6.7 million (~USD $9.4 million) in MatOrtho, to support its international growth and product development.
Founded in 2010, MatOrtho designs, manufactures and commercializes orthopaedic implant devices. The company has achieved...
Private investor clients of Connection Capital, the specialist private client investment business, have invested £6.7 million (~USD $9.4 million) in MatOrtho, to support its international growth and product development.
Founded in 2010, MatOrtho designs, manufactures and commercializes orthopaedic implant devices. The company has achieved strong growth and has built a truly global presence, supplying implant devices into many of the world’s orthopaedic markets.
The MatOrtho range of advanced knee, hip, and finger replacement procedures consistently deliver clinically proven, best-in-class patient outcomes for implant performance and sustained use with better patient satisfaction.
The investment will enable MatOrtho to accelerate international expansion into new and existing markets and will support research and development as the company continues to develop the next generation of implant technology. The management team will be supported by experienced industry figure, Simon Cartmell, previously CEO of ApaTech, who has joined the board as a Non-Executive.
Mike Tuke, Chairman of MatOrtho says, “MatOrtho and Finsbury before that has always led with game changing implants which have established a leading-edge position in the orthopaedic implants sector, and there is still so much potential to develop innovative new products and increase our market penetration. Having the backing of Connection Capital will be invaluable as we look to accelerate the scaling-up of our business.”
Copy to clipboard 
